Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

SELL
$9.4 - $14.04 $23,030 - $34,398
-2,450 Reduced 4.09%
57,384 $542,000
Q2 2023

Aug 14, 2023

SELL
$12.96 - $20.93 $24,818 - $40,080
-1,915 Reduced 3.1%
59,834 $836,000
Q1 2023

May 17, 2023

SELL
$13.48 - $18.79 $27,216 - $37,937
-2,019 Reduced 3.17%
61,749 $1.16 Million
Q4 2022

Feb 08, 2023

SELL
$12.61 - $18.74 $1,916 - $2,848
-152 Reduced 0.24%
63,768 $878,000
Q3 2022

Nov 14, 2022

BUY
$15.33 - $20.36 $49,960 - $66,353
3,259 Added 5.37%
63,920 $1.22 Million
Q2 2022

Aug 16, 2022

BUY
$11.63 - $21.55 $122,463 - $226,921
10,530 Added 21.0%
60,661 $926,000
Q1 2022

May 13, 2022

BUY
$16.63 - $27.73 $3,508 - $5,851
211 Added 0.42%
50,131 $1.02 Million
Q4 2021

Feb 16, 2022

BUY
$20.7 - $34.18 $1.03 Million - $1.71 Million
49,920 New
49,920 $1.46 Million

Others Institutions Holding CDMO

About Avid Bioservices, Inc.


  • Ticker CDMO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,167,500
  • Market Cap $776M
  • Description
  • Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. The company produces monoclonal antibodies and recombinant pro...
More about CDMO
Track This Portfolio

Track Thrivent Financial For Lutherans Portfolio

Follow Thrivent Financial For Lutherans and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Thrivent Financial For Lutherans, based on Form 13F filings with the SEC.

News

Stay updated on Thrivent Financial For Lutherans with notifications on news.